Gulnara Yuldasheva

Dr. Gulnara Yuldasheva

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 October 2012 in Journal of Molecular Structure
Verified
Journal Article
Closed access
GYGulnara Yuldasheva
Gulnara Yuldasheva
GZGeorgii M. Zhidomirov
Georgii M. Zhidomirov
JLJerzy Leszczynski
Jerzy Leszczynski
AIAleksandr I. Ilin
Aleksandr I. Ilin

18 January 2012 in Biotechnology and Applied Biochemistry
Verified
Journal Article
Closed access
PDF file
GYGulnara Yuldasheva
Gulnara Yuldasheva
GZGeorgii M. Zhidomirov
Georgii M. Zhidomirov
AIAleksandr I. Ilin
Aleksandr I. Ilin

20 February 2023 in ACS Omega
Verified
Journal Article
Open access
GYGulnara Yuldasheva
Gulnara Yuldasheva
RARadka Argirova
Radka Argirova
AIAleksander Ivanovich Ilin
Aleksander Ivanovich Ilin
Drugs Armenicum and FS-1 are a solution of ionic nanostructured complexes of alpha-dextrin. In the active centers of these drugs, located inside the dextrin helix, molecular iodine has such an electronic form that minimizes toxic effects in the human body, so these drugs can be used for parenteral and oral administration. On the human lymphoblastoid cell line MT-2, the effect of the antiviral action of FS-1 against HIV-1 was established. Literature data on the results of treatment of people with HIV infection with Armenicum are presented. The mechanism of anti-HIV action of drugs Armenicum and FS-1 was proposed by the molecular modeling method. Using the DFT/B3PW91/6-31G** approach, it was shown that LiI(Cl)I2 active center drugs of Armenicum and FS-1 can be segregated from the dextrin helix and can form a complex with the ACT nucleotide triplet, which is part of a specific fragment of viral DNA that binds to the active center of integrase. The formation of this complex is a key moment in the mechanism of anti-HIV drug action. Molecular iodine and lithium halide, which are part of the active complexes, inhibit the active center of the catalytic domain of the integrase. A new nucleoprotein complex is created that destroys the nucleoprotein preintegration complex (PIC) and inhibits the HIV DNA and the active center of the catalytic domain, while a new N-I bond appears in the viral DNA in the cytosine pyrimidine cycle.

18 May 2016
Verified
Book Chapter
Closed access
PDF file
GYGulnara Yuldasheva
Gulnara Yuldasheva
GZGeorgii M. Zhidomirov
Georgii M. Zhidomirov
JLJerzy Leszczynski
Jerzy Leszczynski
AIAleksandr I. Ilin
Aleksandr I. Ilin

13 December 2021 in Quantum Reports
Verified
Journal Article
Open access
PDF file
GYGulnara Yuldasheva
Gulnara Yuldasheva
AKAssel Kurmanaliyeva
Assel Kurmanaliyeva
AIAlexandr Ilin
Alexandr Ilin
Chromatographic analysis shows that the ionic nanostructured complex of the FS-1 drug contains nanocomplexes of α-dextrin with a size of ~40–48 Å. Based on good agreement between the UV spectra of the model structures and the experimental spectrum of the FS-1 drug, the structure of the active FS-1 nanocomplex is proposed. The structure of the active centers of the drug in the dextrin ring was calculated using the quantum-chemical approach DFT/B3PW91. The active centers, i.e., a complex of molecular iodine with lithium halide (I), a binuclear complex of magnesium and lithium containing molecular iodine, triiodide (II), and triiodide (III), are located inside the dextrin helix. The polypeptide outside the dextrin helix forms a hydrogen bond with dextrin in Complex I and coordinates the molecular iodine in Complex II. It is revealed that the active centers of the FS-1drug can be segregated from the dextrin helix and form complexes with DNA nucleotide triplets. The active centers of the FS-1 drug are only segregated on specific sections of DNA. The formation of a complex between the DNA nucleotide and the active center of FS-1 is a key stage in the mechanisms of anti-HIV, anti-coronavirus (Complex I) and antibacterial action (Complex II).

Verified
Journal Article
Open access
PDF file
Daniil ShepilovDaniil Shepilov
Daniil Shepilov
DADana Askarova
Dana Askarova
ASAnar Seisembekova
Anar Seisembekova
STSeitzhan Turganbay
Seitzhan Turganbay
AJArdak Jumagaziyeva
Ardak Jumagaziyeva
SKSabina Kenesheva
Sabina Kenesheva
Due to the increasing threat of antibiotic resistance and the emergence of new pathogenic strains, the development of effective combined therapeutic agents represents a crucial direction in the fight against infections. Within this study, several compounds were synthesized in which iodine is present in a coordination complex with antibiotics—sodium sulfadimidine and gentamicin sulfate. The physicochemical parameters of these compounds were investigated using capillary electrophoresis and UV spectroscopy, along with their cytotoxicity, antimicrobial, and antiviral activities. As a result of this work, two stable compounds, KC-246 and KC-248, were synthesized, demonstrating virus-inhibitory activity against herpes simplex virus and influenza A under extremely low cytotoxicity levels of 0.018–0.106 mg/mL. Additionally, they exhibited antimicrobial activity against representatives of the families Staphylococcaceae, Pseudomonadaceae, Enterobacteriaceae, Enterococcaceae, and yeast-like fungi. The minimum bactericidal concentrations (MBCs) ranged from 0.794 µg/mL to 0.198 µg/mL (KC-246) and from 2.093 µg/mL to 0.523 µg/mL (KC-248).